ID: ALA5208734

Max Phase: Preclinical

Molecular Formula: C20H19N3O

Molecular Weight: 317.39

Associated Items:

Representations

Canonical SMILES:  Cc1ccc2nc(NCc3ccco3)n(Cc3ccccc3)c2c1

Standard InChI:  InChI=1S/C20H19N3O/c1-15-9-10-18-19(12-15)23(14-16-6-3-2-4-7-16)20(22-18)21-13-17-8-5-11-24-17/h2-12H,13-14H2,1H3,(H,21,22)

Standard InChI Key:  HAPAJSUBIFPWJG-UHFFFAOYSA-N

Associated Targets(Human)

Short transient receptor potential channel 5 300 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 317.39Molecular Weight (Monoisotopic): 317.1528AlogP: 4.60#Rotatable Bonds: 5
Polar Surface Area: 42.99Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.63CX LogP: 4.66CX LogD: 4.60
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.58Np Likeness Score: -1.70

References

1. Chen L, Zhang Z, Tian H, Jiang S, Ji Y, Liu M, Shen J, Cao Z, Wang K..  (2022)  Synthesis of AC1903 analogs as potent transient receptor potential canonical channel 4/5 inhibitors and biological evaluation.,  68  [PMID:35653869] [10.1016/j.bmc.2022.116853]

Source